Blackstone reconsiders future of Japanese pharma — report
Blackstone is reportedly pondering the future of Ayumi Pharmaceutical, the Japanese pharma company it struck a deal to acquire three years ago.
Unnamed sources …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.